About Acadia Pharmaceuticals Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved
Sulzer is a leading engineering company with a proud heritage of innovation. Join our global team to grow your expertise and develop innovative solutions that enable a prosperous and more sustainable society. About the role The
Position Purpose Partnering closely with global and regional Global Regulatory Affairs colleagues, as well as Global Operations stakeholders, to address regulatory strategy challenges and deliver innovative, timely regulatory CMC solutions that meet evolving regulatory and compliance
About Acadia Pharmaceuticals Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved
Company: Description: Investments Sales Leader – Endowments, Foundations & Single-Family Offices, Europe Location - any of our major European city hubs. Marsh People and Investments has an established a strong regional presence in the Endowments, Foundations
Investments Sales Leader – Endowments, Foundations & Single-Family Offices, Europe Location - any of our major European city hubs. Marsh People and Investments has an established a strong regional presence in the Endowments, Foundations and Single-Family
Position Summary: Responsible for oversight of commercial Contract Manufacturing Organizations (CMO’s), and other third-party suppliers for products as identified, including the transfer of processes from R&D/Product development to commercial third-party suppliers. Responsible for oversight of ongoing manufacturing
About Acadia Pharmaceuticals Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved